Earnings Releases·Nov 9, 2026, 7:00 AM ET

Ispire Technology Inc. — Q1 Fiscal Year 2027 Earnings Summary

Revenue decreased 9.3% year-over-year to $27.5 million due to restrictive European regulations but increased 3.2% sequentially; gross margin recovered to 16.2% from 6.3% in the prior quarter.
Net loss narrowed to $6.4 million ($0.11 per share) from $13.8 million in Q4 fiscal 2026, though it widened from $3.3 million in Q1 fiscal 2026, driven by a $4.8 million credit loss expense.
Adjusted EBITDA returned to positive territory at $136,000, an improvement of $2.4 million from the prior quarter, while cash and restricted cash declined to $15.7 million.
Management anticipates cash flow improvement as new manufacturing programs scale in fiscal 2027 and expects to update investors on a significant Southeast Asian OEM/ODM deal in the coming months.
The company is advancing strategic initiatives including a U.S. pilot for the IKE 2.0 age-gating platform and a joint venture with Jincheng Pharma for the nicotine pouch market.